Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
3
×
third rock ventures
3
×
amgen
biotech
boston blog main
boston top stories
cancer
cancer drugs
ipo
revolution medicines
roche
san francisco
sanofi
the column group
warp drive bio
acadia pharmaceuticals
adverum biotechnologies
aimmune
alk
avalon ventures
aveo oncology
biogen
bristol-myers squibb
cerevel therapeutics
clinical data
cobimetinib
colorectal cancer
deals
drug pricing
drugs
egfr
gene therapy
glaxosmithkline
ifm therapeutics
investing
What
cancer
3
×
drug
ipo
medicines
proteins
research
revolution
advanced
arrival
award
bio
cancer’s
data
death
decades
dems
despite
disease
family
frontiers
given
hardest
hit
hottest
hunters
immunotherapy
known
longer
lung
maps
medical
parlance
pharmaceutical
play
pricing
quick
ras
reach
reels
revealed
Language
unset
Current search:
cancer
×
" third rock ventures "
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
